Sep 07, 2017 12:00 pm UTC| Business
SAN FRANCISCO, Sept. 07, 2017 -- Degreed, the world’s first career-long learning platform, today announced Alexandra Cavoulacos as the opening keynote speaker, and Dan Lyons as the closing keynote speaker, for Degreed...
Nuvaira Announces Four Clinical Abstracts Accepted for Presentation at ERS International Congress
Sep 07, 2017 12:00 pm UTC| Business
MILAN, Italy, Sept. 07, 2017 -- Nuvaira, a developer of medical devices to treat obstructive lung diseases, today announced that four scientific abstracts featuring the Nuvaira™ Lung Denervation System have been...
Sep 07, 2017 12:00 pm UTC| Business
PASADENA, Calif., Sept. 07, 2017 -- NextGate, a global leader in patient and provider identification, announced today that Radiology and Imaging Specialists (RIS) has selected its Enterprise Master Patient Index (EMPI)...
Heraeus Implements JAGGAER eProcurement Solution
Sep 07, 2017 12:00 pm UTC| Business
VIENNA, Austria, Sept. 07, 2017 -- JAGGAER, producers of the world's most comprehensive Source to Pay (S2P) solutions suite, today announced that Heraeus, a leading international technology group based out of Hanau,...
Hamilton Lane Partners with Philadelphia’s Cristo Rey High School
Sep 07, 2017 12:00 pm UTC| Business
BALA CYNWYD, Pa., Sept. 07, 2017 -- Hamilton Lane (NASDAQ:HLNE) announced it has once again partnered with Cristo Rey Philadelphia, an independent, Catholic, college preparatory school for students of all faiths who...
Duluth Holdings Celebrates Grand Opening of its Twenty-Fifth Store in Thornton, Colorado
Sep 07, 2017 12:00 pm UTC| Business
BELLEVILLE, Wis., Sept. 07, 2017 -- Duluth Holdings Inc. (dba, Duluth Trading Company) (“Duluth Trading”) (NASDAQ:DLTH), a lifestyle brand of men’s and women’s casual wear, workwear and accessories, today announced the...
Sep 07, 2017 11:50 am UTC| Business
PRINCETON, N.J., Sept. 07, 2017 -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's healthcare company, today announced that an abstract presenting data from the Phase 3 SECURE study of its investigational low-dose...